This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Park, S.-E. Articles by Katzenellenbogen, B. S. Search for Related Content PubMed PubMed Citation Articles by Park, S.-E. Articles by Katzenellenbogen, B. S.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, March 2005, p. 1989-1999, Vol. 25, No. 5
0270-7306/05/$08.00+0     doi:10.1128/MCB.25.5.1989-1999.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Genetic Deletion of the Repressor of Estrogen Receptor Activity (REA) Enhances the Response to Estrogen in Target Tissues In Vivo

Department of Molecular and Integrative Physiology, University of Illinois, Urbana, Illinois,¹ Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas²

Received 25 August 2004/ Returned for modification 10 October 2004/ Accepted 1 December 2004

We previously identified a coregulator, repressor of estrogen receptor activity (REA), that directly interacts with estrogen receptor (ER) and represses ER transcriptional activity. Decreasing the intracellular level of REA by using small interfering RNA knockdown or antisense RNA approaches in cells in culture resulted in a significant increase in the level of up-regulation of estrogen-stimulated genes. To elucidate the functional activities of REA in vivo, we have used targeted disruption to delete the REA gene in mice. The targeting vector eliminated, by homologous recombination, the REA exon sequences encoding amino acids 12 to 201, which are required for REA repressive activity and for interaction with ER. The viability of heterozygous animals was similar to that of the wild type, whereas homozygous animals did not develop, suggesting a crucial role for REA in early development. Female, but not male, heterozygous animals had an increased body weight relative to age-matched wild-type animals beginning after puberty. REA mRNA and protein levels in uteri of heterozygous animals were half that of the wild type, and studies with heterozygous animals revealed a greater uterine weight gain and epithelial hyperproliferation in response to estradiol (E2) and a substantially greater stimulation by E2 of a number of estrogen up-regulated genes in the uterus. Even more dramatic in REA heterozygous animals was the loss of down regulation by E2 of genes in the uterus that are normally repressed by estrogen in wild-type animals. Mouse embryo fibroblasts derived from heterozygous embryos also displayed a greater transcriptional response to E2. These studies demonstrate that REA is a significant modulator of estrogen responsiveness in vivo: it normally restrains estrogen actions, moderating ER stimulation and enhancing ER repression of E2-regulated genes.

This article has been cited by other articles:

• Ross, J. A., Nagy, Z. S., Kirken, R. A. (2008). The PHB1/2 Phosphocomplex Is Required for Mitochondrial Homeostasis and Survival of Human T Cells. J. Biol. Chem. 283: 4699-4713 [Abstract] [Full Text]  
• Merkwirth, C., Dargazanli, S., Tatsuta, T., Geimer, S., Lower, B., Wunderlich, F. T., von Kleist-Retzow, J.-C., Waisman, A., Westermann, B., Langer, T. (2008). Prohibitins control cell proliferation and apoptosis by regulating OPA1-dependent cristae morphogenesis in mitochondria. Genes Dev. 22: 476-488 [Abstract] [Full Text]  
• He, B., Feng, Q., Mukherjee, A., Lonard, D. M., DeMayo, F. J., Katzenellenbogen, B. S., Lydon, J. P., O'Malley, B. W. (2008). A Repressive Role for Prohibitin in Estrogen Signaling. Mol. Endocrinol. 22: 344-360 [Abstract] [Full Text]  
• Kasashima, K., Ohta, E., Kagawa, Y., Endo, H. (2006). Mitochondrial Functions and Estrogen Receptor-dependent Nuclear Translocation of Pleiotropic Human Prohibitin 2. J. Biol. Chem. 281: 36401-36410 [Abstract] [Full Text]  
• Mussi, P., Liao, L., Park, S.-E., Ciana, P., Maggi, A., Katzenellenbogen, B. S., Xu, J., O'Malley, B. W. (2006). Haploinsufficiency of the corepressor of estrogen receptor activity (REA) enhances estrogen receptor function in the mammary gland. Proc. Natl. Acad. Sci. USA 103: 16716-16721 [Abstract] [Full Text]  
• Zubovych, I., Doundoulakis, T., Harran, P. G., Roth, M. G. (2006). A missense mutation in Caenorhabditis elegans prohibitin 2 confers an atypical multidrug resistance. Proc. Natl. Acad. Sci. USA 103: 15523-15528 [Abstract] [Full Text]  
• Corcoran, D, Fair, T, Park, S, Rizos, D, Patel, O V, Smith, G W, Coussens, P M, Ireland, J J, Boland, M P, Evans, A C O, Lonergan, P (2006). Suppressed expression of genes involved in transcription and translation in in vitro compared with in vivo cultured bovine embryos.. Reproduction 131: 651-660 [Abstract] [Full Text]  
• Rastogi, S., Joshi, B., Fusaro, G., Chellappan, S. (2006). Camptothecin Induces Nuclear Export of Prohibitin Preferentially in Transformed Cells through a CRM-1-dependent Mechanism. J. Biol. Chem. 281: 2951-2959 [Abstract] [Full Text]  
• Hall, J. M., McDonnell, D. P. (2005). Coregulators in Nuclear Estrogen Receptor Action: From Concept to Therapeutic Targeting. Mol. Interv. 5: 343-357 [Abstract] [Full Text]